Unitedhealth Group Inc
Q2 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: +2.15%.
Did UNH Beat Earnings? Q2 2025 Results
UnitedHealth Group delivered a deeply troubled second quarter, missing Wall Street's earnings expectations by a wide margin even as revenue held roughly in line. Adjusted EPS of $4.08 fell 8.27% short of the $4.45 consensus estimate and represented a steep decline from the year-ago period's $6.80, while revenue of $111.62 billion edged just 0.03% above estimates and grew 12.9% year-over-year. The defining story was a severe deterioration in medical costs: the consolidated medical care ratio surged 430 basis points to 89.4%, as Medicare Advantage cost trends ran at roughly 7.5% against pricing assumptions of just over 5%, and $1.20 billion in discrete charges, including $620 million tied to the individual exchange business, compressed operating margins sharply. With peers like Elevance Health also struggling under similar cost pressures, the sector-wide pain is hard to ignore. UnitedHealth reinstated full-year 2025 guidance calling for adjusted EPS of at least $16.00 and revenue of $445.50 to $448.00 billion, while already pricing 2026 Medicare Advantage benefits for cost trends accelerating toward 10%.
- Medical cost trends significantly exceeded pricing trends, including both unit costs and intensity of services
- Medicare Advantage medical cost trend running at ~7.5% vs. 2025 pricing expectation of just over 5%
- Consolidated medical care ratio of 89.4% increased 430 basis points year-over-year
- $1.2 billion of unfavorable discrete impacts including $620 million related to individual exchange business
- Medical reserve development was $70 million unfavorable in Q2 2025
- Ongoing effects of Medicare funding reductions and V-28 risk model transition
- Optum Insight performance improved due to reduced impacts from Change Healthcare cyberattack
- Optum Rx growth driven by new clients and expansion in existing client relationships
- UnitedHealthcare membership grew 770,000 year-to-date to 50 million people served
- Operating cost ratio improved to 12.3% from 13.3% year-over-year
“UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly. As we strengthen operating disciplines, positioning us for growth in 2026 and beyond, the people at UnitedHealth Group will continue to support the millions of patients, physicians and customers who rely on us, guided by a culture of service and longstanding values.”
UnitedHealth Group CEO, on the earnings call
Forward Guidance & Outlook
UnitedHealth Group re-established its full year 2025 outlook after suspending it on May 13. The company expects 2025 revenues of $445.5 billion to $448.0 billion, GAAP net earnings of at least $14.65 per share, and adjusted earnings of at least $16.00 per share. The medical care ratio is expected to be 89.25% ± 25 basis points, the operating cost ratio 12.75% ± 25 basis points, operating margin 4.8%-5.0%, and the tax rate ~18.5%. Cash flows from operations are expected to be ~$16.0 billion. Optum revenue is expected at $266.0-$267.5 billion with operating earnings of $12.55-$12.85 billion. UnitedHealthcare revenue is expected at $344.0-$345.5 billion with operating earnings of $9.0-$9.3 billion. The company expects to return to earnings growth in 2026, with Medicare Advantage pricing and benefit designs for 2026 anticipating medical cost trends accelerating to nearly 10%.
UNH YoY Financials
UNH Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.